Wk 5, Case 3 - Review

Please note: Items with dashed lines (--) are information withheld as it is not relevant for you to arrive at the correct findings and impression for the report and/or it was withheld for privacy information. The items were left in to show you the typical information documented in a PET report.

Clinical Indication:
---year-old male with history of T3apN0, Gleason 4+4=8 prostate cancer. The patient has a rising PSA, most recently 0.54 on 6/1/2022. The present study is performed for restaging.

Technique:
Radiopharmaceutical: ----mCi of F-18 piflufolastat (PSMA, Pylarify) administered IV at---- at----.
Incubation interval: -- minutes.
Oral contrast: -----.
Positioning: Arms raised.
PET/CT scanner: Siemens Biograph 40 mCT.
PET/CT acquisition: Vertex-to-mid-thighs.
Standardized uptake value (SUV): Corrected for ----.
CT: Low-dose, non-breath-hold, without intravenous contrast.
TOTAL DLP (Dose Length Product): -----mGy.cm.

Comparison/Correlation:
--

Findings:
Technical quality:-----
Measurements: Unless otherwise specified, all SUVs refer to maximum value in the target.
CT linear measurements performed on axial images.


Head and Neck:
No suspicious PSMA-avid lesions within the head and neck.
No suspicious PSMA-avid or pathologically enlarged adenopathy.
Diffusely enlarged thyroid gland showing multiple bilateral nodules.


Chest:
No suspicious PSMA-avid lesions within the chest.
No suspicious PSMA-avid or pathologically enlarged hilar or mediastinal adenopathy.
Few mildly PSMA-avid hilar and subcarinal lymph nodes, likely inflammatory.
Small non-PSMA-avid noncalcified 11 mm right lower lobe cavitary nodule.
No other suspicious pulmonary nodules or masses.
No pleural effusion, pericardial effusion or pneumothorax.


Abdomen and Pelvis:
No suspicious PSMA-avid lesions within the abdomen and pelvis.
No suspicious PSMA-avid or pathologically enlarged retroperitoneal or pelvic adenopathy.
Surgical changes of prostatectomy with no suspicious focal PSMA activity at surgical bed.
Bilateral non-obstructing renal calculi.
Diverticulosis.
Otherwise, unremarkable liver, gallbladder, spleen, pancreas, kidneys and adrenals.
No ascites.


Skeleton and Soft Tissues:
No suspicious PSMA-avid osseous or soft tissue lesions.
No aggressive lytic or sclerotic lesions.
Multilevel degenerative changes.

Impression:
1. No suspicious PSMA-avid activity at prostatectomy bed to suggest recurrent disease.
2. No evidence of PSMA-avid regional or distant metastatic disease.